Search
community › ... › child-psychiatry-access-network
… care in their practice. CPAN has been modeled after similar programs in 35 states and has been shown to be … mental health experts. Feedback from both providers and families has been positive, reflecting the program’s success. … receive timely and effective care, in line with recommendations from the American Academy of Pediatrics and …
departments › ... › events
… screening, cancer genetic testing, and the importance of family history can be helpful to better understand the chance … College of Medicine The seminar focused on resources in the community, practical tips for day-to-day care, and … Now Ver grabación “Does Genetics Influence Behavior?” May 10 Daryl Scott, M.D., Ph.D., associate professor of …
research › ... › news
… 2026 Jan. 26, 2026 -Welcome postdoctoral scientist Dr. Abdalla Alia to the Chao Lab … recognition! July 18-20, 2025 - The 2025 STXBP1 Summit + Family Meeting in Westminster, Colorado brought together … and EBF3 -related conditions (HADD syndrome and chromosome 10q26 deletion syndrome). Feb. 17, 2025 - Welcome …
departments › ... › fellows
… or residency? My favorite memories from residency come from the day-to-day moments I shared with my … together; those brief pauses in a busy day when we could decompress, share stories from our cases, and just laugh about something completely unrelated to medicine. Why did you choose …
departments › ... › curriculum
… weeks, for a total of 13 blocks per academic year. Overall, combined pediatrics/ medical genetics residents will do two … and two years of genetics intermixed over four years. Combined pediatrics/medical genetics residents spend the … Fourth year, residents do three blocks in pediatrics and 10 blocks in genetics. Two residents are assigned to the …
research › ... › publications
… Liang JH, Poché RA, Samuel MA. Cell Rep. 2021 Feb. 2;34(5):108698. Mouse models to study the pathophysiology of combined methylmalonic acidemia and homocystinuria, cblC … Rodney GG, Dickinson ME, Beeton C, Zhang P, Dirksen RT, Hamilton SL. Skelet Muscle. 2015 Jan 29;5:4. Development and …
news › companies-merge-baylor-cancer-therapies
… – hematology/oncology and a member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. … Marker Therapeutics, Inc., a privately held clinical-stage company to facilitate broader patient access to this … of novel immunotherapies for cancer. “This merger of two companies with complementary technologies will allow us to …
news › device-for-expanded-use-of-donor-lungs
… these extended criteria for transplant reflect less than 10 percent of transplants in the United States. This trial … the transplant, which is even higher than the expected outcome for a standard lung transplant. However, researchers … 48 and 72 hours, the incidence of graft dysfunction was similar to standard donor lungs. “So there is a difference – …
news › new-insight-into-breast-cancer-resistance-to-hormone-therapy
… in Cancer Cell , suggest that a therapeutic approach must combine two different drugs, a SERD (e.g., fulvestrant) to … treat neurofibromin-depleted ER+ breast cancer. When this combination therapy was tested in animal models, the result … in the clinic.” “Neurofibromin loss is present in at least 10% of metastatic ER+ tumors. As a result of these new data, …
news › new-covid-19-vaccine-candidate-option-for-low-to-mid-income-countries
… A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant … people worldwide, especially in low- to middle-income countries. Results from the study, which applied … animals in these groups received three immunizations over 10 weeks. Based on previous HIV studies, the researchers …
